期刊文献+

细胞因子IL-23p19不同长度3'UTR质粒的构建 被引量:1

Plasmid construction of IL-23p19 different length 3'UTR
暂未订购
导出
摘要 目的构建真核表达IL-23p193'UTR质粒(在PGL3中),并且进行鉴定,为调查鼠IL-23p193'UTR区对IL-23p19的表达调控提供条件。方法用mp193'UTR/PGL3-controlvectorDNA作为模板,设计不同长度3'UTR的引物,行聚合酶链反应扩增目的基因,将PCR扩增产物回收,酶切,并克隆到PGL3control载体中,通过酶切鉴定重组质粒。结果构建了4个不同长度的小鼠IL-23p193'UTR区的质粒,经酶切测序鉴定,证实与原设计相同。结论成功构建4个不同长度的小鼠IL-23p193'UTR区的质粒,这4个不同长度的质粒含有不同的ARE区,为进一步调查不同ARE区对小鼠IL-23p19的调节作用提供了物质条件。 Objective To construct and identify eukaryotic expression plasmid IL-23p19 3'UTR(in PGL3) in order to provide conditions for the investigation of the regulation of IL-23p19 by IL-23p193'UTR in mice.Methods Using mp19 3'UTR/PGL3 control vector DNA as a template,designing primers of different length of 3'UTR,polymerase chain reaction amplification of the gene,then the amplification products of PCR were recycled and digested with enzyme,cloned into PGL3 control vector,the recombinant plasmid was identified by restriction enzyme.Results The four different length of IL-23p19 3'UTR region of plasmids in mice were constructed,which were confirmed the same as the original design by sequencing.Conclusion The four different length of IL-23p19 3 'UTR region plasmids in mice are successfully constructed,which contain different ARE areas,so as to provide material conditions for further investigation on the regulatory effect of different ARE on mIL-23p19.
出处 《河北医药》 CAS 2013年第9期1288-1291,共4页 Hebei Medical Journal
基金 河北省应用基础研究计划项目(编号:10966119D)
关键词 IL-23p19 UTR ARE IL-23p19 UTR ARE
  • 相关文献

参考文献14

  • 1Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL- 12p40 to form a cytokine,IL-23 ,with biological activities similar as well as distinct from IL-12. Immunity ,2000,13:715-725.
  • 2Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27 : related but functionally distinct regulators of inflammation. Annu Rev Immuno1,2007,25:221-242.
  • 3Cocco C, Canale S, Frasson C, et al. Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. Blood,2010, 116:3887-3898.
  • 4Kim HR, Cho ML, Kim KW, et patients with rheumatoid arthritis 264. al. The clinical role of IL-23p19 in Scand J Rheumatol, 2007,36 : 259.
  • 5Liu FL,Chen CH,Chu SJ,et al. Interleukin (IL)-23 p19 expression in- duced by IL-1 beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappa B and AP-1 dependent pathway. Rheumatology (O~ord) ,2007,46:1266-1273.
  • 6Adamopoulos IE,Tessmer M,Chao CC, et al. IL-23 is critical for induc- tion of arthritis, osteoelast formation, and maintenance of bone mass. J Immunol, 2011,187 : 951-959.
  • 7Zhang J, Qian X, Ning H, et al. Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1. J Biol Chem,2010,285:21269-21281.
  • 8Marriott JB, Clarke IA, Dalgleish AG. Inhibition of p38 MAP kinase dur- ing cellular activation results in IFN-gamma-dependent augmentation of IL-12 production by human monocytes/macrophages. Clin Exp Immunol, 2001,125:64-70.
  • 9Langrish CL, Chen Y, Blumensehein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med, 2005,201:233-240.
  • 10Lai WS, Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA :tristetraprolin-mediated AU-rich element-dependent mRNA deg- radation can occur in the absence of a poly(A) tail. J Biol Chem,2001, 276:23144-23154.

同被引文献27

  • 1李劲松,叶展,赵涵芳,陈诗书.阳离子脂质体介导的基因转染真核细胞的研究[J].上海第二医科大学学报,2005,25(10):1025-1029. 被引量:8
  • 2宗莉,陈伶俐,张淑芸,杨晓容,朱家壁.壳聚糖纳米粒作为基因载体的研究:制备,特征和对DNA的保护[J].中国药科大学学报,2005,36(6):526-530. 被引量:16
  • 3张新秀,何守志,郭维维,翟所强.PEDF-GFP基因转染大鼠视网膜的实验研究[J].眼科新进展,2006,26(4):265-267. 被引量:7
  • 4毛晓春,张虹,李贵刚.脂质体介导兔角膜内皮细胞基因转染的观察[J].眼科新进展,2007,27(7):485-488. 被引量:1
  • 5Chazenbalk GD, Wang Y, Guo J, et al. Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface. J Biol Chem 2004;279 (49): 51590-51600.
  • 6Mizutori Y, Saitoh O, Eguchi K, et al. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell- induced Graves' hyperthyroidism in mice. J Autoimmun 2006 ; 26 ( 1 ) : 32-36.
  • 7Majumdar R, Raikar R, Dighe RR. Insights into differential modulation of receptor function by hinge region using novel agonistic lutropin receptor and inverse agonistic thyrotropin receptor antibodies. FEBS Lett 2012;586(6) :810-817.
  • 8Iyer S, Bahn R. Immunopathogenesis of Graves' ophthalmopathy : The role of the TSH receptor. Best Prac Res Clin Endocrinol Metab 2012 ;26 (3) : 281-289.
  • 9Hattori Y, Akamizu T, Saijo M, et al. Characterization of the secretable cctodomain of thyrotropin receptor produced by the recombinant baculovirus system. Mol Cell Endocrinol 2001 ; 182 ( 2 ) : 165-174.
  • 10Miller TC, Jaques JT, Szkudlinski MW, et al. Thyrotropic activity of recombinant human glycoprotein hormone analogs and pituitary mammalian gonadotropins in goldfish (Carassius auratus) : Insights into the evolution of thyrotropin receptor specificity. Gen Comp Endocr 2012 ; 177 ( 1 ) :70-75.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部